WMT

120.7

+1.5%↑

COST

984.31

+1.56%↑

KO

83.56

+2.86%↑

PG

149.39

+0.75%↑

PM

182.84

+2.6%↑

WMT

120.7

+1.5%↑

COST

984.31

+1.56%↑

KO

83.56

+2.86%↑

PG

149.39

+0.75%↑

PM

182.84

+2.6%↑

WMT

120.7

+1.5%↑

COST

984.31

+1.56%↑

KO

83.56

+2.86%↑

PG

149.39

+0.75%↑

PM

182.84

+2.6%↑

WMT

120.7

+1.5%↑

COST

984.31

+1.56%↑

KO

83.56

+2.86%↑

PG

149.39

+0.75%↑

PM

182.84

+2.6%↑

WMT

120.7

+1.5%↑

COST

984.31

+1.56%↑

KO

83.56

+2.86%↑

PG

149.39

+0.75%↑

PM

182.84

+2.6%↑

Search

Lifecore Biomedical Inc

Open

BrancheKonsumgüter defensiv

5.69 1.07

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

5.34

Max

5.75

Schlüsselkennzahlen

By Trading Economics

Einkommen

-8.9M

-15M

Verkäufe

-7.9M

23M

Gewinnspanne

-64.588

Angestellte

382

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

-2.83% downside

Dividenden

By Dow Jones

Nächstes Ergebnis

9. Sept. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

41M

179M

Vorheriger Eröffnungskurs

4.62

Vorheriger Schlusskurs

5.69

Nachrichtenstimmung

By Acuity

50%

50%

64 / 131 Ranking in Consumer defensive

Lifecore Biomedical Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

9. Juni 2026, 23:49 UTC

Market Talk

Nikkei May Fall Following Tech Stock Declines on Wall Street -- Market Talk

9. Juni 2026, 23:45 UTC

Akquisitionen, Fusionen, Übernahmen

Correct: Sigma Healthcare: Has Engaged in Preliminary Discussions in Boots Sale Process

9. Juni 2026, 23:44 UTC

Akquisitionen, Fusionen, Übernahmen

Sigma Healthcare Says No Certainty That Any Transaction Will Eventuate

9. Juni 2026, 23:44 UTC

Akquisitionen, Fusionen, Übernahmen

Sigma Healthcare: Continuously Reviews Opportunities to Create Value For Shareholders

9. Juni 2026, 23:43 UTC

Akquisitionen, Fusionen, Übernahmen

Sigma Healthcare: Has Engaged in Preliminary Discussions to Sell Boots

9. Juni 2026, 23:35 UTC

Market Talk

Oil Rises on Escalating Supply Disruption Concerns -- Market Talk

9. Juni 2026, 22:06 UTC

Akquisitionen, Fusionen, Übernahmen

Samsung: Element Has Expanded Rapidly Since 2022 Launch of AVITI

9. Juni 2026, 22:05 UTC

Akquisitionen, Fusionen, Übernahmen

Samsung: Element to Speed Commercialization of Gene-Sequencing Products

9. Juni 2026, 22:05 UTC

Akquisitionen, Fusionen, Übernahmen

Samsung: Additional Investment Makes It Largest Shareholder in Element

9. Juni 2026, 22:05 UTC

Akquisitionen, Fusionen, Übernahmen

Samsung Electronics Raises Stake in Element Biosciences With $175 Million Investment

9. Juni 2026, 20:51 UTC

Ergebnisse

Micron, Marvell, Super Micro, Coherent, Smucker, and More Stocks That Explain Today's Market -- Barrons.com

9. Juni 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

9. Juni 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

9. Juni 2026, 20:09 UTC

Market Talk

Cryptocurrency Traders Look for Bitcoin Bottom -- Market Talk

9. Juni 2026, 19:36 UTC

Market Talk

Cattle Climbs as Crude Oil Falls -- Market Talk

9. Juni 2026, 19:32 UTC

Market Talk

Barclays Oil Price Outlook Contingent on Hormuz Reopening -- Market Talk

9. Juni 2026, 19:25 UTC

Market Talk

U.S. Natural Gas Futures Slip in Rangebound Trade -- Market Talk

9. Juni 2026, 19:00 UTC

Market Talk

Oil Settles Lower on Continued Hopes for Middle East Deal -- Market Talk

9. Juni 2026, 18:52 UTC

Akquisitionen, Fusionen, Übernahmen

Warner Bros. Stock Hits a Low. Its Paramount Merger Return Is Getting Buzz. -- Barrons.com

9. Juni 2026, 18:47 UTC

Market Talk

No World Cup Inflation Seen So Far in Mexico -- Market Talk

9. Juni 2026, 18:37 UTC

Market Talk

Canada's Cooling Trade With the U.S. -- Market Talk

9. Juni 2026, 18:27 UTC

Market Talk

Precious Metals Lower as Trump Vows Military Response -- Market Talk

9. Juni 2026, 17:35 UTC

Market Talk

Treasury Yields, Dollar Briefly Rise on Trump's Iran Retaliation Threat -- Market Talk

9. Juni 2026, 17:30 UTC

Market Talk

Trump Post on Apache Helicopter Causes Brief Spike in Oil -- Market Talk

9. Juni 2026, 16:34 UTC

Market Talk

Cryptocurrency Weakness Follows Selling in Equities -- Market Talk

9. Juni 2026, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

9. Juni 2026, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

9. Juni 2026, 16:20 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Health Care Roundup: Market Talk

9. Juni 2026, 15:28 UTC

Market Talk

Gold Futures Fall Further as Rate Fears Prevail -- Market Talk

9. Juni 2026, 15:25 UTC

Market Talk

Oil Extends Losses, Falling More Than 3.5% -- Market Talk

Peer-Vergleich

Kursveränderung

Lifecore Biomedical Inc Prognose

Kursziel

By TipRanks

-2.83% Nachteil

12-Monats-Prognose

Durchschnitt 5.5 USD  -2.83%

Hoch 6 USD

Tief 5 USD

Basierend auf 4 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Lifecore Biomedical Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

4 ratings

3

Buy

1

Halten

0

Sell

Stimmung

By Acuity

64 / 131 Ranking in Konsumgüter defensiv

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Lifecore Biomedical Inc

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
help-icon Live chat